• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

Medicinal Products

  • Homepage
  • Medicinal Products
  • For Patients
  • News on Safe Use of Medicinal Products

European Medicines Agency has started the review of third- and fourth-generation combined oral contraceptives

30.01.2013

Due to a recent initiative to reduce the use of third- and fourth-generation combined oral contraceptives, the European Medicines Agency has been requested by France to review the benefits risks ratio of third- and fourth-generation (so called "newer" combined oral contraceptives) combined oral contraceptives. The review of benefits risks ratio is being carried out in order to determine whether there is a need to restrict the use of these medicinal products to women who cannot take other combined oral contraceptives. The EMA’s Pharmacovigilance Assessment Committee (PRAC) will be reviewing whether the currently available product information on combined oral contraceptives provides the best information possible for patients and doctors to take appropriate healthcare decisions. New information about the review by the PRAC will be available by the end of next week.
You may find further details in the continuation of this information.

more

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • Medicinal Products Database
  • Information On Medicinal Products
  • Instructions for Applicants
  • Drug utilisation
  • Pharmacopoeia
  • Variation Applications - Referrals, PSUSA Procedures and PRAC Signals
  • Official Medicines Control Laboratory Division - OMCL
  • For Patients
    • Generic and Original Medicinal Products - Equally Safe and Efficacious
    • Use Antibiotics Responsibly and Consciously
    • Questions and Answers on Combined Contraceptives
    • Medicinal Products and Internet
    • How to Report a Suspected Adverse Reaction (ADR)
    • News on Safe Use of Medicinal Products
      • Archive 2022
      • Archive 2018
      • Archive 2017
      • Archive 2016
      • Archive 2015
      • Archive 2014
      • Archive 2013
      • Archive 2012
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2023. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.